These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22894634)

  • 1. Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk.
    Duntas L; Micic D
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):797-803. PubMed ID: 22894634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH; Brenta G
    Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiposopathy is "sick fat" a cardiovascular disease?
    Bays HE
    J Am Coll Cardiol; 2011 Jun; 57(25):2461-73. PubMed ID: 21679848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
    Bays H; Blonde L; Rosenson R
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity, energy regulation and thyroid function: is borderline elevated TSH-level the cause or secondary phenomenon of obesity].
    Dietlein M; Kahaly G; Kobe C; Schmidt M; Derwahl KM; Schicha H
    Nuklearmedizin; 2008; 47(5):181-7. PubMed ID: 18852923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
    Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
    Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
    Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
    Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease.
    Couillard C; Mauriège P; Prud'homme D; Nadeau A; Tremblay A; Bouchard C; Després JP
    Diabetologia; 1997 Oct; 40(10):1178-84. PubMed ID: 9349599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.
    Bays HE
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1429-45. PubMed ID: 19900026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid disease and the cardiovascular system.
    Danzi S; Klein I
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):517-28. PubMed ID: 24891175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
    Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid diseases, dyslipidemia and cardiovascular pathology.
    Neves C; Alves M; Medina JL; Delgado JL
    Rev Port Cardiol; 2008 Oct; 27(10):1211-36. PubMed ID: 19178025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.
    Santini F; Marzullo P; Rotondi M; Ceccarini G; Pagano L; Ippolito S; Chiovato L; Biondi B
    Eur J Endocrinol; 2014 Oct; 171(4):R137-52. PubMed ID: 25214234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lifestyle modification on adipocytokine levels in obese patients.
    De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2008; 12(1):33-9. PubMed ID: 18401970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subclinical thyroid disease--should we treat, should we screen for it?].
    Trbojević B
    Srp Arh Celok Lek; 2003; 131(11-12):467-73. PubMed ID: 15114790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormones, cytokines, physical training and metabolic control.
    Steinacker JM; Brkic M; Simsch C; Nething K; Kresz A; Prokopchuk O; Liu Y
    Horm Metab Res; 2005 Sep; 37(9):538-44. PubMed ID: 16175490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.